Instances of altered gut microbiomes among Irish cricketers over periods of travel in the lead up to the 2016 World Cup: A sequencing analysis by Ciara M., O’ Donovan et al.
Contents lists available at ScienceDirect
Travel Medicine and Infectious Disease
journal homepage: www.elsevier.com/locate/tmaid
Instances of altered gut microbiomes among Irish cricketers over periods of
travel in the lead up to the 2016 World Cup: A sequencing analysis
Ciara M. O’ Donovana,b,c, Brendan Connore, Sharon M. Madigand, Paul D. Cottera,b,∗,
Orla O’ Sullivana,b
a Teagasc Food Research Centre, Moorepark, Fermoy, Co, Cork, Ireland
bAPC Microbiome Ireland, University College Cork, Cork, Ireland
c School of Microbiology, University College Cork, Cork, Ireland
d Sport Ireland Institute, National Sports Campus, Dublin 15, Ireland
e Cricket Ireland, Dublin, Ireland








A B S T R A C T
Background: Changes and stresses experienced during travel have the potential to impact the gut microbiome,
with travel implicated in the spread of antibiotic resistance genes across continents. The possibility of gut mi-
crobiome-mediated negative impacts arising from travel, and consequences for peak performance, would be of
particular concern for elite athletes.
Methods: Faecal samples were collected from male (N = 14) and female (N = 7) cricket players during the
build-up to the 2016 Cricket World Cup. Baseline and post-travel samples were collected from all participants
and subjected to 16S rRNA amplicon sequencing. Samples from a subset of participants (N = 4) were also
analysed by shotgun metagenomic sequencing.
Results: Analysis revealed a single travel time point as having the potential to have an impact on the gut mi-
crobiome. Reductions in alpha diversity following travel were observed, accompanied by shifts in the taxonomic
profile of the gut microbiome. Antibiotic resistance and virulence genes were also identified as undergoing
changes following travel.
Conclusions: This study reveals that periods of travel, in particular following gastrointestinal distress, may result
in gut microbiome disruption. While this analysis was completed in athletes, the findings are applicable to all
travelling individuals and considerations should be made surrounding travel in an attempt to reduce these
changes.
1. Introduction
Many aspects of a modern lifestyle including diet, pharmacological
agents, exercise, and disease state influence the gut microbiome, which
in turn can impact significantly on host health [1–11]. It is hoped that
by gaining a better understanding of factors that modulate the gut
microbiome, it will be possible to more successfully mitigate undesir-
able changes and enhance health.
Recently, there has been an increased focus on the gut microbiome
of athletes and its contribution to athlete health and performance
[4,5,12]. Many athletes travel extensively to train and compete, facing
changes in time zone, stress, diet, and gastrointestinal (GI) dis-
turbances, which may in turn result in gut microbiome alterations
[13–17]. The 2020 Olympics in Japan is an upcoming occasion of travel
for a range of athletes worldwide. The consideration of the potential
implications of travel is important for travelling athletes and their
coaches [18].
Gut microbiome composition prior to travel may also be important
in relation to the impact of travel on antibiotic resistance gene acqui-
sition during travel [19,20]. Some gut microbiota-associated risks that
are particularly enhanced as a consequence of travel include an in-
creased exposure to antibiotic resistance [21]. Additionally, traveller's
diarrhoea (TD), a disorder commonly experienced by individuals who
travel, in particular to Asia, can result in gut microbiota alterations
[22,23].
Anecdotal evidence from Cricket Ireland suggested travel was
having a major impact on GI wellbeing, which subsequently impacted
performance. This study set out to characterise the gut microbiota of
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the Cricket Ireland teams during the build-up to the Cricket World Cup
of 2016 and, more specifically, to determine if travel was associated
with gut microbiota fluctuations. During this period the male team
travelled to multiple destinations, i.e., Zambia/Namibia, Australia,
United Arab Emirates (UAE), and India, while the female team travelled
to India. Faecal samples were collected before and after each journey
and subjected to amplicon sequencing. Additionally, samples from a
subset of participants underwent shotgun metagenomic sequencing to
allow for greater exploration of compositional, as well as functional,
changes. While the approach taken does not offer the possibility of
discerning between the relative impacts of the many different potential
modulating factors involved in long distance travel, it provides an in-
sight into the net impact of such travel on the athlete gut microbiome.
2. Materials and methods
Ethical approval for the study was granted by the clinical research
ethics committee of the Cork teaching hospitals. COD, SM, BC, PC, and
OOS declare that they have no conflict of interest. Faecal samples were
collected from male (N = 14) and female (N = 7) cricket players
during the build-up to the 2016 Cricket World Cup using Omnigene-Gut
collection kits (DNA Genotek Inc., Ottawa, Canada) to facilitate the
stabilisation of the faecal microbiota of samples at room temperature
[24,25]. Baseline faecal samples were collected from female partici-
pants before travel (Time point LA; N = 7) and following a 30-day tour
to India (Time point LB; N = 7). For males, baseline faecal samples
were also collected before travel commenced (Time point A; N = 9) and
again following travel to Zambia/Namibia (Time point B; N = 11), an
extended stay back in Ireland (Time point C; N = 12), and following
subsequent travel to Australia (Time point D; N = 12), UAE (Time point
E; N = 9), and India (Time point F; N = 11) (supplementary figure A1).
Male players stayed at the various destinations, i.e., Zambia/Namibia,
Australia, UAE, and India, for 23, 30, 8, and 18 days, respectively.
DNA extraction was completed using the PowerFecal DNA Isolation
kit (MoBio laboratories inc., Carlsbad, California, USA) using the al-
tered manufacturer's instructions for use with the Omnigene-Gut col-
lection kits. All samples were prepared for 16S rRNA sequencing on the
Illumina Miseq system according to the 16S library preparation work-
flow. A subset of samples from the 4 male participants who provided
samples at all 6 time points (players 1, 2, 3, and 11) were also prepared
for shotgun metagenomic sequencing on the Illumina NextSeq system
as per modified Nextera XT DNA library preparation protocol
(Illumina). All samples were sequenced at the Teagasc sequencing fa-
cility. The datasets generated and analysed during the current study are
available in the European Nucleotide Archive under the study accession
number PRJEB28338.
Resulting FastQ forward and reverse reads from amplicon sequen-
cing were joined using FLASH, clustered into Operational Taxonomic
Units (OTU's) and chimeras removed using USEARCH, and taxonomy
was assigned using Silva123 [26–28]. Resulting FastQ reads from
shotgun metagenomic sequencing were quality checked by first re-
moving contaminating human derived sequences using the NCBI Best
Match Tagger, and trimmed and poor quality and duplicate reads were
removed using a combination of Picard and SAM tools. Taxonomic
classifications were determined using Kaiju [29]. Strain level profiling
was completed using StrainEst [30]. Functional profiling was com-
pleted using HUMAnN2 [31]. Antibiotic resistance associated genes
were determined using the MEGARes pipeline [32]. Reads were also
analysed against the 2017 virulence factors marker collection using
ShortBRED [33].
Analysis of resulting taxonomic and functional tables was completed
in R. Alpha diversities were generated in R using the Phyloseq package
for amplicon sequencing data [34]. An UPGMA representation of Bray-
Curtis dissimilarities was made using QIIME and visualised using iToL
for amplicon sequencing data [35,36]. Bray-curtis distance matrices
were computed using the R package vegan for the shotgun dataset [37].
LEfSe was used to determine taxa which characterise specific groups
[38]. Binary Jaccard distances were calculated using the R package
proxy [39]. Spearman correlations were calculated in R using the
RcmdrMisc package (version 1.0–6) and corrected for multiple com-
parisons using Holms method.
Full materials and methods are available as supplementary docu-
ment A.1.
Fig. 1. Alpha diversity fluctuations occur during travel.
Alpha diversity measures for (A) female (N = 7) and (B) male (N = 9) groups at baseline at home (pink) and post-India (orange) time points, from amplicon datasets.
(C) Shannon and (D) Simpson alpha diversity measures over time for compositional and functional data for samples sequenced by shotgun metagenomic sequencing
(N = 4). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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3. Results
3.1. Timing of gastrointestinal distress symptoms may influence stability of
the gut microbiome
Within sample (alpha) diversity was not found to significantly vary
between baseline and final (i.e., post-India) time points (Fig. 1 A and B).
Subtle shifts were seen in individuals over time with a mean decrease
observed, though not significant (p = 0.1–0.64). Fig. 1 C (Shannon)
and D (Simpson) shows shifts in alpha diversity measures across all time
points for individuals where shotgun data was available. Fluctuations in
alpha diversity measures occurred in all cases, with larger shifts ob-
served within some individuals.
Between group (beta) diversity measured by UPGMA (an un-
weighted hierarchical cluster method) analysis (amplicon data; sup-
plementary figure A2 C and D), and MDS analysis (shotgun data; sup-
plementary figure A2 A and B), revealed that samples cluster by
individual regardless of when they were collected. However, some ex-
ceptions were observed in both datasets, with one example being the
samples collected from player 11. More specifically, the composition, of
both amplicon and shotgun metagenomic sequencing, and functional
potential from player 11 corresponding to the post-India sample di-
verged from that of other samples collected from the same individual.
To assess stability of the microbiome binary Jaccard distances were
computed for each pair of samples from the respective male partici-
pants to understand subtle changes to community composition (Fig. 2).
From the shotgun dataset, at species level, samples from players 2 and
11 can be seen to be variable. Players 2 and 11 reported GI distress
symptoms at 3 and 2 time points, respectively. Both of these individuals
reported GI distress symptoms at time point E, leading us to postulate
that the timing of GI distress, i.e. before travel to India, could result in
instability in the gut microbiome composition.
3.2. Individual taxa are unique between baseline and post-India time points
While individual specific responses to travel could be observed from
the amplicon dataset (supplementary figure A.3), 13 taxa were identi-
fied as discriminatory for the baseline (7 taxa) or post-India (6 taxa)
time points (Fig. 3). Differences based on travel time points were only
identified in the amplicon dataset, which may be as a consequence of
the small number of samples (N = 4) at each of the time points in the
shotgun metagenomic sequencing dataset. Discriminatory taxa were
only established for the baseline and post-India time points, indicating
that perhaps while fluctuations in individual taxa happen during other
time points (i.e. post-Zambia and -Namibia, at home, post-Australia, or
post-UAE time points) these two time points are the most distinct in
terms of composition. This finding may also have been as a consequence
of the comparably lower number of samples available for these time
points as only male participants travelled to these destinations. Sta-
phylococcus, Staphylococcaceae, Ruminiclostridium 5, Incertae Sedis
Lachnospiraceae, Erysipelotrichaceae UCG003, Ruminococcus 1, and
Dorea were found to be associated with baseline samples, while
Fig. 2. Individual variability in microbiome stability.
Binary Jaccard distances were calculated between time points available for each individual. Boxplots show distances for each individual in (A) the genera classified in
the amplicon sequencing dataset and (B) the species classified in the shotgun metagenomic sequencing dataset. Binary Jaccard distances between individuals were
compared using the Kruskal-Wallis test, with a Mann-Whitney U test performed for significant results to determine the players between which this difference applied.
P values were corrected for multiple comparisons using the Benjamini-Hochberg method. *P < 0.05; **P < 0.01; ***P ≤ 0.001.
C.M. O’ Donovan, et al. Travel Medicine and Infectious Disease xxx (xxxx) xxxx
3
Enterococcus, Enterococcaceae, Actinobacteria, Nocardiaceae, Cor-
ynebacteriales, and Rhodococcus were found to be associated with post-
India samples.
Shotgun data allowed a more in-depth analysis of the taxonomic
profiles in a subset of samples, with a total of 126 species being iden-
tified across these 24 samples (Fig. 4 A). Taxonomic profiles based on
shotgun metagenomic sequencing data were found to be individual
specific. Of particular interest, Escherichia coli was identified in samples
F011 and F002 (i.e. post-India samples from players 2 and 11). These
samples were of particular interest as they did not cluster with other
samples from those individuals on an MDS plot (supplementary figure
A2 A). To further analyse this result strain level analysis was completed
Fig. 3. Significant differences in composition based on time point.
LEfSe plots identifying discriminatory taxa between baseline (N = 16) and post-India (N = 16) time points where both female and male participants are grouped
from amplicon sequencing data. An LDA effect size cut off of 2 was used.
Fig. 4. Shotgun metagenomic sequencing reveals unique Escherichia coli strains between participants post-India.
(A) Hierarchical cluster analysis, with species level taxonomic profiles of individual players over time for whom shotgun metagenomic sequencing data was available
(N = 4). Individual bars are coloured by participant, while colours of stacked bar alongside tree represent time point at which sample was collected. Individual
numbers relate to one player and letters relate to time point (A: male baseline at home, B: male post-Zambia and -Namibia, C: male at home, D: male post-Australia, E:
male post-UAE, F: male post-India (see Supplementary Fig. A1 for timeline)). Each bar represents an individual sample. Each colour represents an individual species
with only those species which were present at> 1% relative abundance shown, with all others grouped as other. (B) Strain level profiles of Escherichia coli in
participants 2 and 11 at the post-India time point. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this
article.)
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for E. coli. Strain level profiles (Fig. 4 B) reveal that while the E. coli
population (2.4% of overall relative abundance) of sample F002 (from
male participant 2) was dominated by E. coli DEC15D (88%), the E. coli
profile of sample F011 (41.5% overall relative abundance) was domi-
nated by E. coli B7A (84%), with only one strain (p0305293.7) shared
between these two samples, indicating that while the time point of
acquisition may have been shared, the source may have varied between
these two individuals.
3.3. Individual taxa are associated with gastrointestinal distress symptoms
LEfSe revealed 20 taxa which were associated with GI distress
(Fig. 5), 7 of these were identified from amplicon analysis (A), while 13
were identified from shotgun metagenomic sequencing analysis (B).
Ruminiclostridium 9, Enterococcaceae, Enterococcus, Lentisphaerae,
Victivallaceae, Victivallales, and Victivallis were found to be associated
with reported GI distress from the amplicon dataset. Interestingly,
crossover was not observed between those taxa identified as being as-
sociated with GI distress from the shotgun metagenomic sequencing
dataset; this may be as a result of the variance in the databases used in
each of these analyses. Ascomycota, Clostridium sp. CAG 245-30-32,
Armatimonadetes, Armatimonadetes bacterium Cent15-Ar3, Clostridium
sp. CAG 440, Klebsiella pneumoniae, Klebsiella, Flavobacteriales, Flavo-
bacteriia, and 4 species of Prevotella (namely P. copri CAG 164, P. sp.
CAG 732, P. sp. 885, and P. sp. Marseille P4119) were identified as
being associated with reported GI distress in the shotgun metagenomic
sequencing dataset.
3.4. Antibiotic resistance potential is altered as a consequence of travel to
India
Overall alterations in gut microbiome functional potential were
observed with travel. Further investigations analysed antibiotic re-
sistance and virulence genes, as these are of particular relevance to
travel medicine. Players 2 and 11 showed an increase in the number of
antibiotic resistance genes identified at the post-India time point (Fig. 6:
F002 and F011). Prior to this time point antibiotic resistance remained
individual specific across both of these participants. Post-India, re-
sistance potential to 8 antibiotic classes was seen to increase in both of
these participants, while in addition resistance potential to a further 4
antibiotic classes was seen to increase in player 11 at this time point.
Notably, players 2 and 11 reported GI distress symptoms at the post-
UAE time point (E). While GI distress symptoms were reported at other
time points (player 2 at time points B and D; player 3 at time points D
and F; and player 11 at time point E), no increase in antibiotic re-
sistance potential was observed following these events. It is possible
that the period of GI distress symptoms combined with other factors
encountered during travel to India contributed to the acquisition of
antibiotic resistance genes. It also is important to note that player 11
had received antibiotic treatment in the three months prior to the
collection of sample F. However, no antibiotic usage was reported for
player 2. A corresponding investigation of virulence marker genes also
identified changes here, in particular in post-India samples (supple-
mentary figure A4 A and B).
4. Discussion
Individuals, who travel on a regular basis, including athletes, are
susceptible to stress, time zone changes, alterations in diet, and symp-
toms such as travellers’ diarrhoea (TD) [17,40,41]. While the impacts of
these factors on performance have been variable, associations between
international travel with injury potential and reduced performance
have been identified [42–46]. Identification of undesirable changes that
occur within the gut microbiota during travel might result in the de-
velopment of therapeutics to maintain health. To this end, this pilot
study of 21 individuals was carried out and a number of notable
changes in microbiome composition, diversity, and functional potential
were observed.
The main finding of this research was the establishment that a
specific event, in this case travel to India, can have a significant impact
on gut microbiome composition and functional potential, with asso-
ciated increases in antibiotic resistance and virulence genes. Other
destinations were not identified in this study as having a significant
impact on the gut microbiome; however, this finding may be as a result
of a larger number of samples available for baseline and post-India time
points (i.e., samples from both female and male groups), in comparison
to other time points.
Relative stability in the human gut microbiome is expected over
Fig. 5. Significant differences in composition based on reported gastrointestinal distress symptoms.
LEfSe plots identifying discriminatory taxa from (A) amplicon analysis and (B) shotgun metagenomic sequencing, between those who reported (A: N = 10; B: N = 7)
and did not report gastrointestinal distress symptoms (A: N = 22; B: N = 17). Taxonomy was assigned to the amplicon dataset using Silva123 and to the shotgun
metagenomic sequencing dataset using Kaiju. An LDA effect size cut off of 2 was used.
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time, with perturbations occurring for example with disease states and
antibiotic use. However, the microbiome is also resilient allowing for
the return to a stable composition in most situations [47]. Here, for the
majority, microbial stability is observed, however in certain individuals
instability of the gut microbiome was observed. This is consistent with
very many studies that have established the stability and resilience of
the gut microbiota over time [48–50]. In order to establish an under-
standing of more subtle, individual shifts in the microbiome over time,
binary Jaccard distances (used to estimate stability) were computed.
Timing of reported GI distress symptoms could potentially be an im-
portant factor in any instability noted in the gut microbiome, with
symptoms reported prior to travel to India potentially related to in-
stability post-India. As such a small number of participants fit into these
criteria (2 participants), it is possible that any other number of factors is
influencing these results. Other influencing factors which cannot be
accounted for here include individual variability and dietary impacts.
Potential alterations in stability may be associated with the changes
observed in taxa and antibiotic resistance profiles, with gut microbiome
instability previously associated with diarrhoea, IBS symptoms, and
Clostridium difficle-associated disease [47].
Although travel was found to only induce minimal shifts in the gut
microbiome overall, taxa were identified which were significantly al-
tered at baseline and post-India time points, while another group of
taxa were found to be significantly altered with reported GI distress.
Actinobacteria, found in this study to be associated with the post-India
time point, has previously been identified as increased in IBS [51],
potentially indicating this change could put these individuals at risk of
post-infectious IBS [52]. Of interest, Ruminococcus was identified as
being associated previously with the ability to clear antibiotic re-
sistance post travel, while in this dataset it was associated with baseline
samples, a potentially beneficial finding [19]. Such a relationship could
not be identified in this dataset as it was not possible to collect samples
following an extended period at home post-India.
Noteworthy, from the shotgun dataset, was an increase in E. coli
identified in two participants following travel to India, with these in-
dividuals reporting GI distress at the pre-India time point (i.e. post-
UAE). Escherichia species are among those most frequently identified as
causative for TD and so investigation of this was of particular interest in
this cohort [23]. Strain level differences in E. coli were established
between players 2 and 11, with DEC15D and B7A found to be dom-
inating members, respectively. E. coli DEC15D was sequenced as part of
a collection of diarrheagenic E. coli strains which are a major cause of
diarrhoea, while E. coli B7A is from the B1 subgroup which contains
many commensals but also a number of pathogens [53–55]. This in-
dicated that it is possible that these strains may have been related to GI
distress symptoms experienced by these individuals.
Klebsiella was identified in the shotgun metagenomic sequencing
dataset as being associated with reported GI distress, which has pre-
viously been identified in TD [23]. Prevotella species were identified as
being associated with reported GI distress, with Prevotella previously
associated with diarrhoea predominant IBS, TD, and more abundant
with loose stool [19,56,57]. Of interest, P. copri, one of the species
identified in this dataset as associated with GI distress, has previously
been identified as more abundant in those individuals who experienced
TD even before travel [19]. This pattern was evident to some extent in
our study (i.e. player 2) but would require a shotgun metagenomic
investigation of a larger cohort to establish its significance.
Acquisition of antibiotic resistance potential and virulence marker
genes were explored in the shotgun data, as previous studies have
outlined the potential of acquiring antibiotic resistance during travel,
while the presence of virulence marker genes could reveal regions
where acquisition of potential pathogens is particularly increased
[21,22,50,58]. Acquisition of antibiotic resistance related genes seemed
to be individual specific, with players 2 and 11 acquiring resistance to a
number of new antibiotic classes and also an array of mechanisms of
antibiotic resistance activity. Previous studies into the acquisition of
antibiotic resistance during travel have mainly focused on extended
spectrum β-lactamases (ESBLs) producers, with an increase seen post-
travel across a number of studies [59–63]. Individuals have been found
to be at increased risk of acquiring antibiotic resistance genes if travel
destination is in Asia (particularly India), antibiotics are used during
travel, TD persists after return from travel, and/or as a consequence of
consuming certain foods during travel such as ice-creams and pastry
[60–62]. Travel to India, GI distress, and antibiotic usage could have
been contributing factors in the acquisition of antibiotic resistance
potential in this cohort. Antibiotic resistance is a major global health
problem and the acquisition of antibiotic resistance genes during travel
could impact on global carriage of antibiotic resistance genes [19].
Fig. 6. An increase in antibiotic resistance potential is seen in some individuals post-India.
Antibiotic resistance potential over time characterised using resistome analyser. (A) Resistance to antibiotic classes by participant. (B) Mechanisms of action of
antibiotic resistance potential by participant.
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Carriage of antibiotic resistance genes has the potential to persist for
years and have the potential to transfer to pathogenic bacteria, in-
creasing the risk of acquiring and harbouring an antibiotic resistant
infection [64].
Analysis of virulence marker genes revealed an increase in the alpha
diversity of these marker genes in players 2 and 11 post-India, with a
notable shift in beta diversity also observed for these samples.
Interestingly, in this subset of individuals travel to India resulted in an
increase in nine, individual virulence marker genes. Although the pre-
sence of these genes doesn't necessarily represent functionality or pa-
thogenicity, increases in proportions of virulence and antibiotic re-
sistance genes following travel is a concern and merits further
investigation in the future. Presence of virulence factors in the GI tract
could result in intestinal infections including diarrhoea [55], and thus
presence of these virulence genes could be related to reported GI dis-
tress.
While this study only includes a small number of participants, owing
to the number of travelling members of the Cricket Ireland teams
available and willingness to participate, it further explores the influence
of travel on the gut microbiome. While in this study post-Zambia and
-Namibia, at home, post-Australia, or post-UAE time points were not
found to be associated with major alterations this could be as a result of
the numbers available and so further studies with a larger number to
these destinations may offer differing results. This study identifies
travel to India, and in particular travel to India following GI distress
symptoms, as associated with disturbances in the gut microbiome from
both a compositional and functional potential perspective. Previously,
travel to India has been identified as having a major impact on the gut
microbiome, as has GI distress during travel [60–62].
GI disturbances pre-travel to high risk destinations (e.g. India) could
potentially place individuals at an increased risk of gut microbiome
alterations, including the acquisition of antibiotic resistance genes, and
so individuals falling into this category should in particular take care.
Probiotics have been shown to be beneficial in the prevention of TD if
taken 4 weeks prior to travel. However, as studies vary by strain(s) used
it is not yet possible to recommend one overall option [46,65]. How-
ever, none of the investigations to date have been completed in tra-
velling athletes. Although not investigated in this study, diet changes
during travel may impact on the gut microbiome. To this end, travelling
individuals should take care to avoid those foods associated with the
development of TD including but not limited to any raw and unpeeled
produce, local water, uncooked meats, and unpasteurised dairy pro-
ducts [46,66].
5. Conclusion
Here we have identified one travel period, travel to India, as having
a significant impact on gut microbiome composition, as well as an al-
teration in the antibiotic resistance and virulence genes present. While
individual fluctuations were identified, taxa associated both to pre- and
post-travel time points, as well as experienced GI distress, could be
identified. Individual, pre-travel insults to the GI tract, such as reported
distress or antibiotic usage, could potentially influence the impact of
travel on the gut microbiome. These changes identified during travel
are of particular relevance and interest to athletes travelling for com-
petition, such as for the upcoming 2020 Olympics [18]. Consideration
should be given to potential gut microbiome changes during travel to
reduce potential risk factors and the potential negative impact of these
identified changes. Ultimately, it is hoped that a greater appreciation of
the negative impacts of travel on the gut microbiome of athletes, and
other travellers, can reveal interventions that can minimise undesirable
health consequences.
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